Core Viewpoint - The company has announced the third exercise period of its 2022 stock option incentive plan, allowing 839 eligible participants to exercise a total of 11,111,640 stock options at a price of 3.69 yuan per share, effective from October 29, 2025, to August 25, 2026 [2][12][22]. Group 1: Stock Option Plan Details - The stock options under the 2022 incentive plan are designated as "Daiyang JLC9" with the code 037282 [2]. - The total number of stock options available for exercise represents 0.45% of the company's total share capital [2]. - The exercise price for the options is set at 3.69 yuan per share [22]. Group 2: Exercise Conditions and Procedures - The third exercise period's conditions have been met, and the company has received approval from the Shenzhen Stock Exchange for the exercise process [12][14]. - The actual exercise period for the third tranche is from October 29, 2025, to August 25, 2026 [4][22]. - The company will manage the exercise funds in a dedicated account to supplement its liquidity [46]. Group 3: Impact on Company Structure and Financials - If all options are exercised, the company's total share capital will increase by 11,111,640 shares, maintaining compliance with listing requirements [25]. - The exercise of these options is expected to increase the company's net assets by approximately 41.00 million yuan, with a corresponding increase in capital reserves [25]. - The impact on earnings per share is expected to be minimal, and the overall financial condition will not be significantly affected [25]. Group 4: Adjustments and Compliance - The company has made adjustments to the exercise price in response to its dividend distribution, which is now set at 3.69 yuan per share [18]. - The company has procedures in place to handle stock options that do not meet exercise conditions, which will be automatically canceled [47]. - The company will disclose changes in stock option participants and important parameters in regular reports [27].

对公司股权结构不产生重大影响，公司控股股东和实际控制人不会发生变化，不 会导致公司股权分布不具备上市条件。 （行权后的股本结构表以中国证券登记结算有 限责任公司深圳分公司实际登记为准）。 本次行权相关股票期权费用将根据有关会计准则和会计制度的规定，在等待期内 摊销，并计入相关费用，相应增加资本公积。根据公司《2022 年股票期权激励计划 （草案）》，假设本期可行权的股票期权全部行权，公司总股本将由 7,247,395,805 股 增加至 7,277,513,605 股，对公司基本每股收益及净资产收益率影响较小，具体影响 以经会计师事务所审计的数据为准。 证券代码：002475 证券简称：立讯精密 公告编号：2025-075 债券代码：128136 债券简称：立讯转债 立讯精密工业股份有限公司 关于 2022 年股票期权激励计划第二个行权期 采用自主行权模式的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 行权期可行权的股票期权数量共计 30,117,800 份，行权价格为 29.92 元/股。 任公司深圳分公司的手续已办理完成。 立讯精 ...

| 证券代码：002475 | 证券简称：立讯精密 公告编号：2025-017 | | --- | --- | | 债券代码：128136 | 债券简称：立讯转债 | 立讯精密工业股份有限公司 关于 2021 年股票期权激励计划首次授予第三个行权期 采用自主行权模式的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、2021 年股票期权激励计划首次授予期权简称：立讯 JLC4，期权代码：037192。 2、2021 年股票期权激励计划首次授予符合本次行权条件的 845 名激励对象在 第三个行权期可行权的股票期权数量共计 8,214,326 份，行权价格为 35.33 元/股。 3、本次行权采用自主行权模式。 4、公司 2021 年股票期权激励计划首次授予共五个行权期，第三个行权期可行 权期限为 2025 年 2 月 28 日至 2025 年 12 月 3 日。截至本公告日，中国证券登记结 算有限责任公司深圳分公司的手续已办理完成。 5、本次可行权股票期权若全部行权，公司股份仍具备上市条件。 立讯精密工业股份有限公司（以下简称"立讯精密 ...